GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) » Definitions » Net Margin %

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Net Margin % : 24.11% (As of Dec. 2023)


View and export this data going back to 2019. Start your Free Trial

What is Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Net Income for the three months ended in Dec. 2023 was ₽16.9 Mil. Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Revenue for the three months ended in Dec. 2023 was ₽70.1 Mil. Therefore, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's net margin for the quarter that ended in Dec. 2023 was 24.11%.

The historical rank and industry rank for Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Net Margin % or its related term are showing as below:

MIC:GEMA' s Net Margin % Range Over the Past 10 Years
Min: 36.79   Med: 50.6   Max: 62.71
Current: 36.79


MIC:GEMA's Net Margin % is ranked better than
97.71% of 654 companies
in the Healthcare Providers & Services industry
Industry Median: 1.69 vs MIC:GEMA: 36.79

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Net Margin % Historical Data

The historical data trend for Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Net Margin % Chart

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Margin %
Get a 7-Day Free Trial 49.98 50.60 51.34 38.55 44.36

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.39 34.68 49.63 - 24.11

Competitive Comparison of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Net Margin %

For the Medical Care Facilities subindustry, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Net Margin % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Net Margin % distribution charts can be found below:

* The bar in red indicates where Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Net Margin % falls into.



Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as

Net Margin=Net Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=125.78/283.512
=44.36 %

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=16.91/70.132
=24.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC  (MIC:GEMA) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC Net Margin % Related Terms

Thank you for viewing the detailed overview of Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Business Description

Traded in Other Exchanges
N/A
Address
St. Gubkina, 3, Building 1, Floor 1, Pom. I, r. 24, Moscow, RUS, 119333
Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC, through its subsidiary, is engaged in offering personal storage of cord blood stem cells in Russia and Eastern Europe. The services provided by the company include Cord Blood Cell Preservation, Program for the treatment of Cerebral Palsy, Cord Blood DNA isolation and Umbilical cord tissue among others.

Interntl Medical Center of Biomaterials Processing & Cryostorag PJSC (MIC:GEMA) Headlines

No Headlines